Tocilizumab (Actemra)

Tocilizumab (Actemra)

Tocilizumab (TCZ), is a recombinant humanized anti-interleukin-6 receptor (IL-6R) monoclonal antibody which has a main use in the treatment of rheumatoid arthritis, systemic juvenile idiopathic arthritis (sJIA) and polyarticular juvenile idiopathic arthritis (pJIA). This article provides an overview...

Full description

Bibliographic Details
Main Authors: Martin Sheppard, Faidra Laskou, Philip P. Stapleton, Shahryar Hadavi, Bhaskar Dasgupta
Format: Article
Language:English
Published: Taylor & Francis Group 2017-09-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
giant cell arteritis
interleukin-6
monoclonal antibody
rheumatoid arthritis
tocilizumab
vasculitis
Online Access:http://dx.doi.org/10.1080/21645515.2017.1316909

Internet

http://dx.doi.org/10.1080/21645515.2017.1316909

Similar Items